ISBMT_UPDATES

Official account of Indian Society for Blood & Marrow Transplant.

[ISBMT_UPDATES @IsbmtU]

@MirghSumeet @lingarajnayak @TheEBMT @DrGPrakash @nihardesai89 @Satyayadav__ @AnuraagNalla @GJaishetwar

[ISBMT_UPDATES @IsbmtU]

Steroid-refractory GvHD remains a major challenge post-transplant. New real-world analysis of 43 patients from India evaluates the safety and efficacy of Etanercept in SR-GvHD, offering critical insights from routine clinical practice.

https://t.co/l4WBVZYM7d

[ISBMT_UPDATES @IsbmtU]

This is in an era (2010-2019) when Ruxolitinib was not yet approved for sr GVHD.
- Day 28 response rates of 70%.
- The organ-specific ORR was 70% (lower gut), 67% (skin), and 50% (liver).
- Battling infections in patients with SR-GVHD still remains an unmet need

[ISBMT_UPDATES @IsbmtU]

@TheEBMT_Trainee @TheEBMT @MirghSumeet @nihardesai89 @DrGPrakash @Satyayadav__ @BhayanaSwati @AnuraagNalla

[ISBMT_UPDATES @IsbmtU]

Infection related morbidity and mortality are dreaded complications during HSCT. Listen to experts on how to manage bacterial infections post HSCT.

Tune in to 65th educational webinar of #ISBMT on 4th November, 2026 at 8pm IST.

https://t.co/he0exHi7zX

[ISBMT_UPDATES @IsbmtU]

Congratulations to Dr. Revathi Raj, President of #ISBMT, on being honoured with the “RV Lokeshwar oration” by the @pho_india PHO Chapter of the Indian Academy of Paediatrics at the #PHOCON2026.

@Satyayadav__ @drshweta_pedonc @AnuraagNalla @DrSunilBhat @MirghSumeet @ReetuJain19

[ISBMT_UPDATES @IsbmtU]

@Satyayadav__ @AnnaSureda5 @MirghSumeet @DrSunilBhat @nihardesai89 @DrGPrakash @GJaishetwar

[ISBMT_UPDATES @IsbmtU]

Orca-T, an allogeneic T-cell immunotherapy uses purified donor regulatory T cells to prevent GVHD. In a randomized phase 3 study, Orca-T
significantly improved survival free from
cGVHD compared to conventional alloHSCT with Tac/MTX.

https://t.co/ClKKreqBzf

[Dr.Rachit Khandelwal, MD @dr_khandelwal99]

PTCy is no longer just for haploidentical transplant.

Strong data now support its role even in HLA-matched SCT, with better GVHD outcomes and GVHD-free, relapse-free survival.

#PTCy #HSCT #BMT #GVHD
#APBMT

[ISBMT_UPDATES @IsbmtU]

@DrSunilBhat @BhayanaSwati @ReetuJain19 @DrSunilBhat @pho_india @Prasshmehta

[ISBMT_UPDATES @IsbmtU]

#ISBMT educational webinar #64 - poor graft function & failure are dreaded complications of #HSCT. Listen to Prof Bacigalupo on 7th October between 8 to 9:30pm IST.

@TheEBMT @TheEBMT_Trainee @PalasseryRasmi @Satyayadav__ @MirghSumeet @DrGPrakash @nihardesai89 @AnuraagNalla

[ISBMT_UPDATES @IsbmtU]

#ISBMT clinical grand rounds series #35 tune in at 8pm on 17th September 2026. Listen to the expert panelists @AnnaSureda5 and Dr Mammen Chandy.

Click here to register - https://t.co/eHBN1PAesQ

@DrGPrakash @docarijit @MirghSumeet @TheEBMT @TheEBMT_Trainee @AnuraagNalla

[ISBMT_UPDATES @IsbmtU]

One hour to go!
Do register.

[ISBMT_UPDATES @IsbmtU]

#ISBMT educational webinar series #63 One of the most important steps in any #HSCT is choosing the right conditioning regimen. Learn the principles and what best suits Indian scenario in this webinar!

September 2nd, 8-9:30 pm IST

Register -https://t.co/he0exHi7zX

[ISBMT_UPDATES @IsbmtU]

#ISBMT educational webinar series #63 One of the most important steps in any #HSCT is choosing the right conditioning regimen. Learn the principles and what best suits Indian scenario in this webinar!

September 2nd, 8-9:30 pm IST

Register -https://t.co/he0exHi7zX

[ISBMT_UPDATES @IsbmtU]

Checkout the #ISBMT newsletter - August 2026. Message from Dr Joseph John and working party updates.

[ISBMT_UPDATES @IsbmtU]

Checkout the #ISBMT newsletter - August 2026. Includes reflections from @ReetuJain19 & brief article on Dr Manisha Madkaikar’s pioneering work in #IEI @MirghSumeet @TheEBMT @Satyayadav__ @AnuraagNalla @DrGPrakash @BhayanaSwati

[ISBMT_UPDATES @IsbmtU]

@udaypkulkarni @MirghSumeet @Satyayadav__ @DrGPrakash @AnuraagNalla @GJaishetwar @TheEBMT @EshaKaul1 @DrSunilBhat @BhayanaSwati @lingarajnayak

[ISBMT_UPDATES @IsbmtU]

#ISBMT educational webinar series #63 One of the most important steps in any #HSCT is choosing the right conditioning regimen. Learn the principles and what best suits Indian scenario in this webinar!

September 2nd, 8-9:30 pm IST

Register -https://t.co/he0exHi7zX

[ISBMT_UPDATES @IsbmtU]

https://t.co/zXE0JnKtYs

As we approach the #ChildhoodCancerAwareness month, let’s fight this together 🎗️
@WorldSIOP @AsiaSiop @TheEBMT @Satyayadav__ @drshweta_pedonc @DrManasKalra1 @DrGauravNarula @MirghSumeet @DrGPrakash @Pritampedhemonc @BhayanaSwati @AnuraagNalla @drgargidas

[ISBMT_UPDATES @IsbmtU]

Multidisciplinary collaborative care is what’s needed to improve the outcomes in #Pediatric #oncology. This 10-year analysis of PICU outcomes in PHO from India, post QI-bundle implementation has shown ⬇️ in mortality, MV and RRT rates. @StJudeResearch @pho_india @critcarescience